newsfilter
← Latest News
ACCESS Newswire·

Lexaria's Robust Patent Portfolio Continues to Grow

Lexaria receives 5 new patents including 2 for diabetes treatment utilizing GLP-1 drugsKELOWNA, BC / ACCESS Newswire / March 26, 2026 / Lexaria Bioscience Corp. , , a global